Brief: RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo Solution
29/11/2024 11:47
Nov 29 (Reuters) - RadNet Inc RDNT.O :
* RADNET’S DEEPHEALTH SUBSIDIARY EXPANDS FDA CLEARANCE FOR
SMARTMAMMO™ SOLUTION
* RADNET INC - SMARTMAMMO DX NOW FDA-CLEARED AS COMPATIBLE
FOR GE
HEALTHCARE'S SENOGRAPHE PRISTINA MAMMOGRAPHY SYSTEMS
Source text: ID:nGNX1ncz3q
Further company coverage: RDNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RadNet
See all newsBrief: Radnet And Win-Nextgen™ Form A Collaboration To Inspire The Next Generation Of Medical Imaging Professionals
RadNet, Inc. reports results for the quarter ended June 30 - Earnings Summary
RadNet raises outlook as Q2 revenue jumps 25%, adjusted EPS beats estimates
Brief: RadNet Q2 EPS USD 0.1
Brief: Radnet Secures $250 Million Incremental Term Loan To Fund Strategic Growth Opportunities And Reduces The Interest Rates On Its Credit Facility By 0.25%